NXE:NYE-NexGen Energy Ltd. (USD)

COMMON STOCK | Uranium |

Last Closing

USD 6.66

Change

0.00 (0.00)%

Market Cap

USD 3.53B

Volume

7.19M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NexGen Energy Ltd., an exploration and development stage company, engages in the acquisition, exploration, and evaluation and development of uranium properties in Canada. It holds a 100% interest in the Rook I project that consists of 32 contiguous mineral claims totaling an area of 35,065 hectares located in the southwestern Athabasca Basin of Saskatchewan. The company is headquartered in Vancouver, Canada.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Uranium

Symbol Name Price(Change) Market Cap
UEC Uranium Energy Corp

-0.06 (-0.93%)

USD 2.53B
DNN Denison Mines Corp

-0.02 (-1.06%)

USD 1.58B
UUUU Energy Fuels Inc

-0.05 (-0.89%)

USD 0.88B
LEU Centrus Energy

-0.25 (-0.45%)

USD 0.73B
EU enCore Energy Corp. Common Sha..

-0.01 (-0.23%)

USD 0.70B
URG Ur Energy Inc

-0.04 (-3.25%)

USD 0.44B
CCJ Cameco Corp

+0.47 (+0.99%)

N/A

ETFs Containing NXE

URNU:XETRA Global X Uranium UCITS ET.. 8.79 % 0.00 %

+0.25 (+2.52%)

USD 0.18B
URNU:F Global X Uranium UCITS ET.. 8.79 % 0.00 %

+0.41 (+2.52%)

N/A
URNU:SW Global X Uranium UCITS ET.. 8.79 % 0.00 %

+0.34 (+2.52%)

USD 0.15B
URNG:LSE Global X Uranium UCITS ET.. 8.56 % 0.00 %

+0.22 (+2.52%)

USD 0.15B
DXET:CA Dynamic Active Energy Evo.. 8.27 % 0.00 %

-0.04 (2.52%)

CAD 2.26M
URNU:LSE Global X Uranium UCITS ET.. 7.91 % 0.00 %

+0.41 (+2.52%)

N/A
NUKL:XETRA VanEck Uranium and Nuclea.. 7.01 % 0.00 %

+0.52 (+2.52%)

USD 0.13B
NUCL:SW VanEck Uranium and Nuclea.. 7.01 % 0.00 %

+0.73 (+2.52%)

USD 0.13B
HURA:CA Global X Uranium Index ET.. 6.65 % 0.00 %

+0.34 (+2.52%)

CAD 0.08B
URA Global X Uranium ETF 6.58 % 0.72 %

+0.26 (+2.52%)

USD 2.88B
NUCG:LSE VanEck Uranium and Nuclea.. 6.06 % 0.00 %

+0.38 (+2.52%)

USD 0.13B
ATOM:AU Global X Uranium ETF 5.90 % 0.00 %

+0.38 (+2.52%)

N/A
URNM Sprott Uranium Miners ETF 4.40 % 0.00 %

+0.23 (+2.52%)

USD 1.52B
U3O8:XETRA Sprott Uranium Miners UCI.. 4.39 % 0.00 %

+0.16 (+2.52%)

USD 0.24B
U3O8:F HANetf ICAV - Sprott Uran.. 4.39 % 0.00 %

+0.12 (+2.52%)

N/A
URNP:LSE Sprott Uranium Miners UCI.. 4.34 % 0.00 %

+15.45 (+2.52%)

USD 0.24B
URNM:AU BetaShares Global Uranium.. 4.28 % 0.00 %

+0.32 (+2.52%)

N/A
URNM:LSE Sprott Uranium Miners UCI.. 4.20 % 0.00 %

+0.24 (+2.52%)

N/A
NLR VanEck Uranium+Nuclear En.. 0.00 % 0.60 %

+0.06 (+2.52%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Uranium) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.86% 38% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.86% 38% F 16% F
Trailing 12 Months  
Capital Gain 6.73% 63% D 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.73% 63% D 24% F
Trailing 5 Years  
Capital Gain 400.75% 57% F 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 400.75% 57% F 98% N/A
Average Annual (5 Year Horizon)  
Capital Gain 72.77% 63% D 96% N/A
Dividend Return 72.77% 63% D 96% N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 96.31% 63% D 8% B-
Risk Adjusted Return 75.57% 75% C 88% B+
Market Capitalization 3.53B 100% F 74% C

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.